Main menu

Value of Medicines

Value of Medicines

A collection of papers demonstrating the impact of medicines on public health and the economy.

Future Topics in Development:

  • Papers will soon be available demonstrating value in a variety of areas including Vaccines, Rare Diseases, Atrial Fibrillation-Stroke, Pain, Breast Cancer, and more. Stay tuned!

Pfizer has long maintained that medicines provide tremendous value to individuals and society as a whole. We have now captured that value in a series of concise, easy-to-access papers that detail the societal and economic value provided by medicines that treat various disease areas. The data we provide come from published, peer-reviewed studies and are complemented by real stories from patients who have benefited from medicines. We hope these will serve as a resource to those looking to quantify the value of medicines.

 

Select Infographics from these papers:

 

 

 

 

 

 

From Value of Oncology Medicines: 5-Year Relative Survival Rates for Cancers in US2

 

From Value of Drug Adherence: Return on Investment from Improved Medication Adherence: Diabetes3

 

History of Development: Targeted Treatment Options for Advanced RCC

Thirty-three percent of all smoking-related deaths are from cardiovascular diseases

Total Cost of Diagnosed Diabetes in the US 2007–2012

Smokers in the USA

World Cigarette Consumption

 

From Value of Statins: Societal Health Impact1

 

1 See Value of Statins for multiple references

2 National Cancer Institute, Survival Epidemiology and End Results (SEER), posted to website, viewed at http://seer.cancer.gov/csr/1975_2005/accessible_contents.html in September, 2013.

3 Adopted from: M. Sokol et al., “Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost,” Journal of Medical Care, 2005. Notes: Adherence is the extent to which patients take medicines as prescribed, in terms of dose and duration. Return on Investment estimates reflect spending attributable to the condition listed.